SOTAC
Start SIP
Invest Now
Start SIP in SOTAC
Performance
- Low
- ₹124
- High
- ₹124
- 52 Week Low
- ₹88
- 52 Week High
- ₹152
- Open Price₹124
- Previous Close₹118
- Volume1,200
- 50 DMA₹121.41
- 100 DMA₹122.80
- 200 DMA₹124.16
Investment Returns
- Over 1 Month + 10.79%
- Over 3 Month -3.72%
- Over 6 Month -6.37%
- Over 1 Year + 12.65%
Smart Investing Starts Here Start SIP with Sotac Pharmaceuticals Ltd for Steady Growth!
Sotac Pharmaceuticals Ltd Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 17.1
- PEG Ratio
- -
- Market Cap Cr
- 137
- P/B Ratio
- 2.9
- Average True Range
- 6.11
- EPS
- 6.95
- Dividend Yield
- 0.1
- MACD Signal
- -3.66
- RSI
- 54.4
- MFI
- 65.41
Sotac Pharmaceuticals Ltd Financials
Sotac Pharmaceuticals Ltd Technicals
EMA & SMA
Current Price
₹124.20
+
5.9
(4.99%)
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹117.75
- 50 Day
- ₹121.41
- 100 Day
- ₹122.80
- 200 Day
- ₹124.16
Resistance and Support
124.2
- R3 124.20
- R2 124.20
- R1 124.20
- S1 124.20
- S2 124.20
- S3 124.20
Sotac Pharmaceuticals Ltd Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-12 | Quarterly Results & Others | To consider other business matters. Final Dividend of Rs. 0.1 per equity share. |
| 2025-05-28 | Audited Results, Dividend & Others | To consider other business matters. Final Dividend of Rs. 0.1 per equity share. |
| 2024-10-29 | Quarterly Results | |
| 2024-08-13 | Quarterly Results | |
| 2024-05-17 | Audited Results & Others | To consider other business matters Final Dividend of Rs. 0.1 per equity share. |
Sotac Pharmaceuticals Ltd F&O
About Sotac Pharmaceuticals Ltd
- NSE Symbol
- SOTAC
- BSE Symbol
- Chairman & Managing Director
- Mr. Sharadkumar Dashrathbhai Patel
- ISIN
- INE0O2D01012
Similar Stocks to Sotac Pharmaceuticals Ltd
Sotac Pharmaceuticals Ltd FAQs
Sotac Pharmaceuticals Ltd share price is ₹124 As on 12 February, 2026 | 08:07
The Market Cap of Sotac Pharmaceuticals Ltd is ₹137.2 Cr As on 12 February, 2026 | 08:07
The P/E ratio of Sotac Pharmaceuticals Ltd is 17.1 As on 12 February, 2026 | 08:07
The PB ratio of Sotac Pharmaceuticals Ltd is 2.9 As on 12 February, 2026 | 08:07
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.